This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n15http://linked.opendata.cz/resource/drugbank/drug/DB02571/identifier/chemspider/
n14http://linked.opendata.cz/resource/drugbank/drug/DB02571/identifier/chebi/
n7http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n8http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n10http://linked.opendata.cz/resource/drugbank/drug/DB02571/identifier/pdb/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02571/identifier/kegg-compound/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://linked.opendata.cz/resource/drugbank/drug/DB02571/identifier/pubchem-compound/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n16http://linked.opendata.cz/resource/drugbank/drug/DB02571/identifier/pubchem-substance/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB02571/identifier/drugbank/

Statements

Subject Item
n2:DB02571
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n7:DB02571 n8:DB02571
dcterms:title
2-Amino-6-Oxo-Hexanoic Acid
adms:identifier
n10:DO2 n11:160603 n12:DB02571 n13:C04076 n14:17917 n15:202 n16:46505195
n3:IUPAC-Name
n4:271B43C8-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B43CE-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B43CD-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B43CA-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B43CB-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B43CC-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B43C6-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B43C4-363D-11E5-9242-09173F13E4C5 n4:271B43C7-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B43C5-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B43D4-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B43D5-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B43CF-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B43D0-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B43D2-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B43D1-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B43D3-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B43DA-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B43DC-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B43DD-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B43D9-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B43D8-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B43DB-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B43C9-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B43D6-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B43D7-363D-11E5-9242-09173F13E4C5